Welcome to the second lecture in the Heart University Webinar Series: Contemporary Questions in Congenital Heart Disease
” Single Ventricle Fontan Heart Disease: How can we improve outcomes?
Each expert will give a 10-minute presentation on their controversial topic, followed by a 10-minute discussion amongst moderators and panelists. We will additionally have a brief debate over the use of anticoagulation in this population. The live audience will have the opportunity to type in your questions to help guide the discussion with our expert panel.
Expert Panel and Discussion Topics:
Jolien Roos-Hesselink, MD, PhD, Erasmus Medical Center in Rotterdam
“What should I tell teenage patients about contraception, pregnancy & parenthood?
DEBATE: “Anticoagulation in the Fontan patient.”
Barbara Mulder, MD, PhD, Academic Medical Center in Amsterdam
THESIS: “Direct Oral Anticoagulants should be preferred over Warfarin and antiplatelet medications” - PRO
Brian McCrindle, MD, MPH, FRCPC, FACC, Toronto SickKids
Antithesis: “Direct Oral Anticoagulants should be preferred over Warfarin and antiplatelet medications” - CON
Cedric Manlhiot, PhD, Johns Hopkins
Synthesis: “Making decisions with incomplete information: paths forward.”
Alexander Opotowsky, MD, MMSc, Cincinnati Children’s
“Should I start all my patients on a pulmonary vasodilator?”
Shyam Sunder Kothari, DM, All India Institute
“How does single ventricle management differ in resource-limited settings?”
Rahul Rathod, MD, Boston Children’s
“Can cardiac magnetic resonance make a real difference in guiding therapy?”
**You can receive a certificate of attendance, after viewing the recording. Instructions for downloading this certificate are available with the webinar recording. We are currently working on CME and CEU’s for this webinar. We will notify you once this is available.